Efficacy of Genicular Block on Total Knee Arthroplasty Surgery

ConditionsTotal Knee Anthroplasty Genicular Nerves Block

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorMersin University

About this trial

The aim of this study is to investigate the postoperative pain relieving effect of preoperative genicular block in total knee arthroplasty surgery. The main questions it aims to answer are:

1. Do visual analog scale (VAS) scores decrease in patients who underwent geniculate block? 2. Does opioid consumption decrease in patients who underwent geniculate block?

Researchers will compare postoperative pain in patients who received genicular block with those who did not.One group of patients will be administered 0.25% bupivacaine with the geniculate block method. The other group will not undergo any intervention. Both groups will be administered intravenous morphine for postoperative analgesia.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Scheduled for unilateral and primary total knee arthroplasty

Older than 18 years of age

Disqualifiers

Younger than 18 years

Bilateral knee arthroplasty

Revision case of knee arthroplasty

Trial design

Design model

Parallel

Treatments tested in this trial

Genicular blocks (bupivakain)
Drug
Genicular block is a regional analgesic technique performed with USG
Patient Control Analgesia (PCA) Morphine group
Drug
this group consists of the patients no any intervention preoperatively and they will be given morfin with PCA (Patient controlled analgesia) and paracetamol 3x1000 mg intravenous and diclofenac 75 mg intramuscular (if needed)
Paracetamol (acetaminophen) + Diclofenac Sodium
Drug
All patients are given paracetamol (3x1000 mg) and diclofenac (if needed)

Treatment groups

44 Participants

are divided into 2 treatment groups

Group A: Genicular block groupActive comparator 3 interventions

Group B: patients only given PCA-morfin postoperativelyActive comparator 2 interventions

Trial outcomes

Primary outcomes

Visual Analog Scale Measure

VAS scores are assessed at 0th, 24th and 48th hours post operatively VAS score consists of 0-10 in numbers, the bigger the number the worse the pain

Time frame

0-48 hours

opioid consumption

Morphine consumption is assesed by PCA

Time frame

0-48 hours

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Mersin University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: